MRI in chronic toluene abuse: Low signal in the cerebral cortex on T2-weighted images

Neuroradiology

Volumn 40, Issue 8, 1998, Pages 519-521

  Kamran, S ^a   Bakshi, R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Brain; Iron; Magnetic resonance imaging; Organic solvents; Toluene

Indexed keywords

ORGANIC SOLVENT; TOLUENE;

ADULT; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN CORTEX; BRAIN TOXICITY; CASE REPORT; CEREBELLUM VERMIS; CORPUS CALLOSUM; DIAGNOSTIC VALUE; GRAY MATTER; HUMAN; MALE; MESENCEPHALON; MOTOR CORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBSTANCE ABUSE; VISUAL CORTEX; WHITE MATTER;

ADMINISTRATION, INHALATION; ADULT; ATROPHY; BRAIN; CEREBRAL CORTEX; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; SOLVENTS; SUBSTANCE-RELATED DISORDERS; TOLUENE;

EID: 0031827464     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002340050637     Document Type: Article

References (18)

1. Hormes JT, Filley CM, Rosenberg NL (1986) Neurologic sequelae of chronic solvent vapour abuse. Neurology 36: 698-701
2. Filley CM. Heaton RK, Rosenberg NL (1990) White matter dementia in chronic toluene abuse. Neurology 40: 532-534
3. Ashikaga R, Miura K, Ishida O (1995) Cranial MRI in chronic thinner intoxication. AJNR 37: 443-444
4. Unger E, Alexander A, Fritz T, Rosenberg N, Dreisbach J (1994) Toluene abuse: physical basis for hypointensity of the basal ganglia on T2-weighted MR images. Radiology 193: 473-476
5. Yamanouchi N, Okada S, Kodana K, Hirai S, Murakami A, Sato T (1995) White matter changes caused by chronic toluene abuse. AJNR 16: 1643-1649
6. Caldemeyer KS, Pasuzzi RM, Moran CC, Smith RR (1993) Toluene abuse causing reduced MR signal intensity in the brain. AJR 161: 1259-1261
7. Escobar A, Arufo C (1980) Chronic thinner intoxication: a clinico-pathologic report of a human case. J Neurol Neurosurg Psychiatry 43: 986-994
8. Caldemeyer KS, Armstrong SW, George KK, Pasuzzi RM, Moran CC (1996) The spectrum of neuroimaging abnormalities in solvent abuse and their clinical correlation. J Neuroimaging 6: 167-173
9. Stern MB, Braffman BH, Skolnick BE, Hurtig HI. Grossman RI (1989) Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 39: 1524-1526
10. Drayer BP (1988) Imaging of the aging brain. II. Pathologic conditions. Radiology 166: 797-806
11. Russo C, Smoker WRK. Kubal W (1996) Cortical and subcortical T2 shortening in multiple sclerosis. AJNR 18: 124-126
12. Savoiardo M, Halliday WC, Nardocci N, Strada L, D'Incerti L, Angelini L, Rumi V, Tesoro-Tess JD (1993) Hallervorden-Spaiz disease: MR and pathologic findings. AJNR 14: 155-162
13. Chen JC, Hardy PA, Kucharczyk W, Clauberg M, Joshi JG; Vourlas A, Dhar M, Henkelmann RM (1993) MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR 14: 275-281
14. Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA (1986) MRI of brain iron. AJR 147: 103-110
15. Bakshi R, Lindsay BD, Kinkel PR (1997) Brain Magnetic Resonance Imaging in Clinical Neurology. In: Toynt RT, Griggs RC (eds) Clinical Neurology. Lippincott-Raven, Philadelphia, pp 1-203
16. Rosenberg NL, Kleinschmidt-DeMasters BK, Davis KA, Hormes JT, Filley CM (1988) Toluene abuse causes diffuse white matter changes. Ann Neurol 23: 611-614
17. Ishikawa K, Nagura H, Yokota T, Yamanouchi H (1993) Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis. Ann Neurol 33: 218-222
18. Cheung G, Gawal MJ, Cooper PW, Farb RI, Ang LC (1995) Amyotrophic lateral sclerosis: correlation of clinical and MR findings. Radiology 194: 263-270